D.E. Shaw & Co
ODTX

D.E. Shaw & Co’s Odyssey Therapeutics ODTX Stock Holding History

D.E. Shaw & Co’s Portfolio ODTX Stock Details ODTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$371K Buy
+19,848
New +$348K ﹤0.01% 4323

Other funds holding ODTX

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $2.4B AUM 7.07% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

D.E. Shaw & Co's ODTX Position: Q2 2026 in Review

D.E. Shaw & Co opened a new position in Odyssey Therapeutics (ODTX) in Q2 2026: 19,848 shares worth $371K. The stake represents ﹤0.01% of the portfolio and ranks #4323 among its holdings.

50 funds tracked by Wall St. Rank hold ODTX as of Q2 2026.

  • D.E. Shaw & Co held 19,848 shares of Odyssey Therapeutics worth $371K as of Q2 2026.
  • Odyssey Therapeutics was a new D.E. Shaw & Co position in Q2 2026.
  • Odyssey Therapeutics made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #4323 holding.
  • 50 funds tracked by Wall St. Rank held Odyssey Therapeutics as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.